PharmaBoardroom

Spain Pharma News: Grifols Invests in Nigerian Manufacturing;…

The latest from Spanish pharma, including the Patent and Trademark Office’s warning of the importance of IP protection for medical advancements,…

Zack Pemberton-Whiteley – CEO, Leukaemia Care

Zack Pemberton-Whiteley, CEO of UK-based blood cancer charity Leukaemia Care, discusses the importance of patient and patient organizations’…

Süha Taşpolatoğlu – CEO, Abdi Ibrahim

Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s ambitious bet on biosimilars, their…

Hatice Öncel – CEO, Ilko Pharmaceuticals

Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel explains the company’s investment in…

China Pharma Roundup: Sinopharm Tops Brand Value Rankings;…

The latest news from the Chinese pharmaceutical industry, including recent deals between domestic pharma giant Simcere and German biotech Vivoryon in…

Hamdi Akan – Head of the Executive Board, Clinical Research…

Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and barriers to become a clinical trials…

Senthil Sockalingam – Head of IQVIA Biotech, JAPAC &…

IQVIA Biotech JAPAC’s Dr Senthil Sockalingam outlines the evolving needs of the flood of early-stage drug discovery ventures in Asia, how biotechs…

İsmail Yormaz – VP & Regional Director South-East,…

İsmail Yormaz, Recordati’s VP and regional director for south-east, highlights how the Milan-based company has become a shining example of a…

How Pricing is Straining Turkish Pharma’s Sustainability

Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of universal healthcare coverage to over…

Morocco Signs Recipharm & Sinopharm Deals on Road to…

After implementing the most successful COVID-19 inoculation campaign on the African continent, Morocco is looking to bolster its biologics and vaccine…

Enhancing Patient Engagement in Clinical Trials in Japan

Writing in the July issue of DIA’s Global Forum magazine Pfizer R&D Japan’s Atsushi Kitamura examines how both pharmaceutical companies and…

Decentralised Clinical Trials in APAC Here to Stay

Writing in the July issue of DIA’s Global Forum magazine Serene Ong and Gaurang Majmudar of clinical trial logistics specialists Marken outline why…

Tagged with